Numerous studies discuss and show promising results targets for NSAIDs [116,162,163,164,165,166,167,168], mTOR pathway regulators [169,170,171,172], and FASN inhibitors [75] in viral infection associated cancers but additional in vivo studies need to be done to fully exploit these pathways. The gene discussed is FASN; the disease is viral infectious disease.